Naproxen switches for dysmenorrhoea

The Royal Pharmaceutical Society has welcomed the announcement of the POM to P switch of Naproxen 250mg from Bayer Healthcare.

The product, with the brand name Feminax Ultra, is used in the treatment of primary dysmenorrhoea.

The Society’s Lead Pharmacist for self care, Sadia Khan, says: “The Society welcomes the reclassification and believes that this switch will provide women with more choice, convenience and better access to relief from period pains. It also enables pharmacist to use their skills and expertise in medicines.”